Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A
During this quarter, the company achieved a key milestone of reaching 1,000 DCGI approvals
Takara Bio Europe will distribute MN’s Bioanalysis portfolio in Austria, Belgium, Denmark, France, Germany, Ireland, Luxembourg, Sweden, Switzerland, and the United Kingdom
Friesland Campina Professional’s innovative Kievit portfolio features fat powders, creamers, foamers, whipping agents, cake emulsifiers
The Swiss peptide and oligonucleotide manufacturers roll out major investments across site networks in US, UK and Switzerland
This project builds on a previous joint funding agreement between CARBOGEN AMCIS and the same customer in April 2021
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
Strengthening capabilities in Peptide Therapeutics and CDMO services
Bloom has pioneered a technology to transform plant waste into valuable chemical products
Subscribe To Our Newsletter & Stay Updated
